- Lobbying
- otsuka AND america AND pharmaceutical
Lobbying Arrangements Results for 'Otsuka America Pharmaceutical'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details S.1945 - Mental Health Reform Act of 2015, S.481 - Improving Regulatory Transparency for New Medical Therapies Act, S.1893 - Mental Health Awareness and Improvement Act of 2015, H.R.2624 - Helping ... |
Otsuka Pharmaceutical Development & Commercialization, Inc.
|
in-house lobbying | |||
Details Pharmaceutical reimbursement issues. Issues related to neurological treatments. Corporate tax issues. |
Otsuka America Pharmaceutical, Inc.
|
Thorn Run Partners | |||
Details Education about innovative therapies treating Alzheimer's dementia. H.R.2630 - Safe Step Act. |
Otsuka America Pharmaceutical, Inc.
|
W Strategies, LLC | |||
Details Veterans Affairs, Mental Health, and Posttraumatic stress disorder (PTSD). Specifically health care policies relating to PTSD. Veterans Affairs authorizations and appropriations issues related to P... |
Otsuka America Pharmaceutical, Inc.
|
GOVERNMENT SOLUTIONS LLC | |||
Details S. 1871, the SGR Repeal and Medicare Beneficiary AccessImprovement Act of 2013, S. 2157 Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014, H.R. 4302 Protecting Acess to... |
Otsuka America Pharmaceutical , Inc.
|
Squire Patton Boggs (formerly Patton Boggs LLP) | |||
Details H.R. 1458/S. 723, Access to Prescription Digital Therapeutics Act of 2023. Legislation to establish Medicare and Medicaid coverage for prescription digital therapeutics. |
Otsuka America Pharmaceutical, Inc.
|
BLUEBIRD STRATEGIES | |||
Details H.R. 3717, the Helping Families in Mental Health Crisis Act; H.R. 4574, Strengthening Mental Health In Our Communities Act; 21st Century Cures initiative S. 1871, the SGR Repeal and Medicare Benefi... |
Otsuka America Pharmaceutical, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Access to Prescription Digital Therapeutics Act (S.723/HR 1458). Due Process Continuity of Care Act (S. 971). Implementation of the Inflation Reduction Act. Issues related to Medicare Part D redesi... |
Otsuka America Pharmaceutical, Inc.
|
in-house lobbying | |||
Details Issues related to Mental Health and Digital Medicine |
Otsuka America Phamaceutical, Inc.
|
theGROUP DC, LLC | |||
Details Drug Pricing legislation introduced in the 116th Congress; P.L. 115-271, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act imp... |
Otsuka Pharmaceutical Development & Commercialization, Inc.
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues related to prescription drug pricing. Issues related to Mental Health policies. Issues related to Prescription Digital Therapeutics. Issues related to Post-traumatic stress disorder (PTSD). |
Otsuka America Pharmaceutical, Inc.
|
FEDERAL STREET STRATEGIES, LLC | |||
Details H.R. 6833, Continuing Appropriations and Ukraine Supplemental Appropriations Act of 2023 H.R. 5376, the Inflation Reduction Act Prescription drug access and affordability, 6 protected classes, me... |
Otsuka America Pharmaceutical, Inc.
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details Veterans mental health care and related research programs; Issues related to research studies in the U.S. Government and Veterans Affairs. Issues related to research studies in the U.S. Government ... |
Coalition to Heal Invisible Wounds
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Medicare Coverage of Digital Therapeutics. Medicare Star Ratings. Drug Pricing. Issues relating to mental health as a chronic condition. Agitation in Alzheimer's. Discussions concerning the FY 2024... |
Otsuka America Pharmaceutical, Inc.
|
Todd Strategy Group |